U.S. to resume Johnson & Johnson COVID vaccinations despite rare clot risk

U.S. to resume Johnson & Johnson COVID vaccinations despite rare clot risk

Newsday

Published

Health officials lifted an 11-day pause on COVID-19 vaccinations using the Johnson & Johnson single-dose shot after scientific advisers decided its benefits outweight a rare risk of blood clots.

Full Article